Coronary Artery DiseaseUsefulness of Circulating Decoy Receptor 3 in Predicting Coronary Artery Disease Severity and Future Major Adverse Cardiovascular Events in Patients With Multivessel Coronary Artery Disease
Section snippets
Methods
This study enrolled consecutive patients who were admitted to a tertiary medical referral center for PCI from 2012 to June 2013, with stable CAD and angiographically confirmed multivessel disease, defined as stenosis of ≥50% in ≥2 major epicardial vessels involving ≥2 separate coronary artery territories. Before enrollment, a detailed review of each patient's chart was conducted to gather data on medications, smoking status, and risk factors for CAD, such as age, hypertension, diabetes mellitus
Results
During a 12-month follow-up period to June 2014, 152 patients (110 men and 42 women; mean age 72.5 ± 11.7 years) were enrolled for analysis. Based on coronary angiography, 83 patients had 2-vessel CAD, 69 patients had 3-vessel CAD, and 23 patients were found to have left main disease (the presence of ≥50% stenosis in left main coronary artery).
All study subjects were divided into 3 groups (Table 1). Group 1 was defined as high SXscore (>22), group 2 as intermediate SXscore (>13 and ≤22), and
Discussion
In this study, we elucidate the relation between circulating DcR3 levels and CAD severity and DcR3 as a prognostic factor for patients with advanced atherosclerotic CAD. To the best of our knowledge, this is the first study to address how the increased serum DcR3 levels in patients with stable multivessel CAD who underwent PCI are associated with the severity of CAD determined by SXscore and the occurrence of 1-year MACE in a longitudinal follow-up data set. These findings provide novel
Disclosures
The authors have no conflicts of interest to disclose.
References (30)
- et al.
Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer
Biochem Pharmacol
(2011) - et al.
The relationship between kidney function and angiographically-derived SYNTAX score
Can J Cardiol
(2011) - et al.
A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis
J Biol Chem
(1999) - et al.
TL1A is a TNF like ligand for DR3 and TR6_DcR3 and functions as a T cell costimulator
Immunity
(2002) - et al.
High intestinal and systemic levels of decoy receptor 3 (DcR3) and its ligand TL1A in active ulcerative colitis
Clin Immunol
(2010) - et al.
Circulating levels of TNF-like cytokine 1A (TL1A) and its decoy receptor 3 (DcR3) in rheumatoid arthritis
Clin Immunol
(2008) - et al.
Serum decoy receptor 3, a potential new biomarker for sepsis
Clin Chim Acta
(2012) - et al.
Circulating levels of TNF-like cytokine 1A correlate with the progression of atheromatous lesions in patients with rheumatoid arthritis
Clin Immunol
(2013) - et al.
Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial
J Am Coll Cardiol
(2010) - et al.
Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and >80 years) (from the New York State Angioplasty Registry)
Am J Cardiol
(2006)
The scope of coronary heart disease in patients with chronic kidney disease
J Am Coll Cardiol
Quantification and detection of DcR3, a decoy receptor in TNFR family
J Immunol Methods
Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis
Arterioscler Thromb Vasc Biol
Five-year outcomes in patients with left main disease treated with either percutaneous coronary intervention or coronary artery bypass grafting in the synergy between percutaneous coronary intervention with Taxus and Cardiac Surgery trial
Circulation
Decoy receptor 3, a novel inflammatory marker, and mortality in hemodialysis patients
Clin J Am Soc Nephrol
Cited by (0)
Drs Chang and Hsu contributed equally and both are first authors of this work.
This study was supported, in part, by the following research grants: VGH-V103A-009, VGH-V102B-016 and VGH-V102E2-002 from the Taipei Veterans General Hospital (Taipei City, Taiwan) and a grant from the Taipei Veterans General Hospital-National Yang-Ming University-Excellent Physician Scientists Cultivation Program (Taipei City, Taiwan), No.103-V-B-049. Funding agencies had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.
See page 1032 for disclosure information.